NANO MRNA Co.,Ltd.
4571.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| % Growth | -19.9% | -33% | -23.4% | – |
| Cost of Goods Sold | ¥0 | ¥0 | ¥0 | ¥0 |
| Gross Profit | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 72% | 81.9% | 78.9% | 84.4% |
| R&D Expenses | ¥0 | ¥1 | ¥1 | ¥2 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥1 | ¥0 | ¥0 | ¥0 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | -¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥1 | ¥1 | ¥1 | ¥2 |
| Operating Income | -¥1 | -¥1 | -¥1 | -¥2 |
| % Margin | -696.1% | -637.9% | -616.3% | -780.6% |
| Other Income/Exp. Net | -¥0 | ¥0 | -¥0 | ¥0 |
| Pre-Tax Income | -¥1 | -¥1 | -¥1 | -¥2 |
| Tax Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Net Income | -¥1 | -¥1 | -¥1 | -¥2 |
| % Margin | -769.8% | -575.6% | -648.4% | -712.7% |
| EPS | -11.85 | -11.1 | -18.7 | -26.9 |
| % Growth | -6.8% | 40.6% | 30.5% | – |
| EPS Diluted | -11.85 | -11.1 | -18.7 | -26.9 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥0 | ¥0 | ¥0 | ¥0 |
| EBITDA | -¥1 | -¥1 | -¥1 | -¥2 |
| % Margin | -767.2% | -636.9% | -616.2% | -779.4% |